High Cost Not Impacting Demand GLP-1 medications, originally developed to manage Type 2 diabetes, became popular for its off-label effect on weight loss
The share of the largest firms covering these medications for weight loss increased significantly in 2025, but many of these firms also reported higher than expected use, as well as a significant impact on prescription costs
The goal is that a users journey feels continuous and personalized, not siloed by platform
If you get approved, you will get instructions about how much you need to take, how to use it, and what you need to watch for during the treatment
As each episode or relapse of active lupus nephritis implicates CKD progression, preventing flares of lupus nephritis is a key treatment target